Immatics IMTX
NASDAQ IMTX
$9.43 -0.03 (-0.32%)
As of: Sep 4, 2026 · 3:09 PM EDT

Immatics (IMTX) EBT (2019 - 2026)

Immatics (IMTX) posted EBT of -$41.4 million for Q4 2025, up 30.12% sequentially from -$59.2 million in Q3 2025, and down 189.53% YoY from $46.2 million in Q4 2024.

Analysis

Immatics (IMTX) EBT (2019 - 2026) Analysis & Trends

Immatics has reported EBT for 7 years, with the latest figure at -$41.4 million in Q4 2025.

  • Quarterly EBT fell 189.53% year-over-year to -$41.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$224.4 million (down 1094.55% YoY) and the FY2025 annual result came in at -$224.2 million, down 1070.39% from the prior year.
  • EBT grew to -$41.4 million in Q4 2025 per IMTX's latest filing, from -$59.2 million in the prior quarter.
  • Over five years, EBT peaked at $96.1 million in Q1 2022 and troughed at -$80.8 million in Q2 2025.
  • A 5-year average of -$18.3 million and a median of -$24.0 million in 2023 frame the typical range for EBT.
  • The sharpest annual moves came in 2022 and 2025: EBT soared 449.38% in 2022, then slumped 2196.9% in 2025.
  • Over 5 years, EBT stood at -$19.2 million in 2021, then soared by 44.68% to -$10.6 million in 2022, then sank by 164.82% to -$28.1 million in 2023, then jumped by 264.36% to $46.2 million in 2024, then tumbled by 189.53% to -$41.4 million in 2025.
  • According to Business Quant data, EBT over the past three periods registered -$41.4 million, -$59.2 million, and -$80.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 1.39 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 1.53 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 542.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -767.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - -644.37 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 312.46 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 177.81 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 81.49 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -11.37 Mn
10 Immatics 1.15 Bn 696.53 Mn - -72.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -72.96 Mn
Mar 31, 2026 -67.62 Mn
Dec 31, 2025 -41.40 Mn
Sep 30, 2025 -59.24 Mn
Jun 30, 2025 -80.76 Mn
Mar 31, 2025 -42.97 Mn
Dec 31, 2024 46.24 Mn
Sep 30, 2024 -2.58 Mn
Jun 30, 2024 -19.22 Mn
Mar 31, 2024 -1.87 Mn
Dec 31, 2023 -28.13 Mn
Sep 30, 2023 -28.84 Mn
Jun 30, 2023 -26.80 Mn
Mar 31, 2023 -21.20 Mn
Dec 31, 2022 -10.62 Mn
Sep 30, 2022 -20.55 Mn
Jun 30, 2022 -13.70 Mn
Mar 31, 2022 96.14 Mn
Dec 31, 2021 -19.20 Mn
Sep 30, 2021 -32.08 Mn